Welcome to our dedicated page for Phibro Animal news (Ticker: PAHC), a resource for investors and traders seeking the latest updates and insights on Phibro Animal stock.
Phibro Animal Health Corporation reports developments in animal health, mineral nutrition and performance products for food-animal markets. The company develops, manufactures and markets antibacterials, anticoccidials, nutritional specialty products, vaccines and mineral nutrition products for poultry, swine, beef and dairy cattle, and aquaculture in the United States and international markets.
Recurring PAHC news includes quarterly results and guidance, cash dividend declarations on Class A and Class B common stock, investor conference participation and regulatory updates affecting antimicrobial products such as virginiamycin and bacitracin. Company updates also address product portfolio activity, acquisition-related effects, input and distribution costs, foreign-currency impacts and tools such as PhibroVet for veterinary prescription management.
Phibro Animal Health Corporation (NASDAQ:PAHC) will release its first quarter financial results on November 4, 2020, after market close. A conference call and webcast are scheduled for November 5, 2020, at 9:00 AM ET.
Investors can participate in the call via phone or through a webcast available on the company's investor relations website. A replay will be accessible two hours after the live event. Phibro develops and supplies a wide range of animal health and nutrition products to support sustainable livestock production.